Arcturus therapeutics received approval from singapore health sciences authority to proceed with phase 2 study of arct-021 (lunar-cov19) vaccine candidate and provides new and updated clinical and preclinical data

San diego--(business wire)---- $arct #clinicaltrial--arcturus received approval from singapore hsa to proceed with phase 2 study of its vaccine candidate & provides new/updated clinical/preclinical data
ARCT Ratings Summary
ARCT Quant Ranking